Blood Analyzers in Texas

Germaine Laboratories, Inc. is an FDA-registered manufacturer and distributor of in vitro diagnostic tests and reagents serving medical, drug testing, veterinary, and food & beverage industries since 1990. The company holds ISO 13485:2016 certification for quality management systems applicable to diagnostic test manufacturing. Product portfolio includes urinalysis reagent strips (AimStrip®), hemoglobin testing systems (AimStrip® Hemoglobin), strep detection tests (StrepAim®), pregnancy tests (AimStep®), blood glucose monitoring systems (VQPet H for veterinary use), COVID-19 antigen home tests (Flowflex™), and reducing substance tablets for food testing (AimTab™). The company serves physician offices, walk-in clinics, pharmacies, hospitals, drug court programs, schools, workplaces, veterinary practices, and food & beverage manufacturers. All products are CLIA-waived where applicable and FDA-approved. Germaine Laboratories operates as both a manufacturer and distributor, offering bulk packaging, private labeling, OEM arrangements, and exclusive distributorship opportunities. The company provides laboratory services and tableting contract manufacturing capabilities. Customer service and technical support are available 24/7 via phone and email, with emphasis on rapid response and order fulfillment.

Ansh Labs, a VION Biosciences company based in Webster, Texas, is a specialized biotechnology firm founded in 2010 that develops, manufactures, and distributes high-quality immunodiagnostic assays, reagents, and ELISA kits for biomedical research and clinical diagnostics. The company leverages in-house antibody development and characterization capabilities to create immunoassays targeting clinically significant biomarkers. Ansh Labs offers validated ELISA immunoassays with rapid turnaround times, high specificity, and excellent sensitivity—supporting 24-month shelf lives and straightforward procedures. Core service offerings include contract development of custom immunoassays, immunoassay method development and validation, assay optimization, cross-reactivity testing, and preclinical biomarker testing. The company serves life science researchers, hospitals, commercial laboratories, and public health agencies, with particular expertise in areas such as cancer diagnostics, fertility biomarker testing, obesity research, and specialty assays for glucagon regulation and reproductive health. Following its acquisition by VION Biosciences in August 2024, Ansh Labs continues to maintain its team and product portfolio while expanding its service capabilities.

Babson Diagnostics operates BetterWay, a clinical laboratory and direct-to-consumer blood testing service offering fingerstick capillary blood collection at convenient locations. The company provides affordable, medically accurate blood tests with results delivered in 1–2 days. BetterWay's test menu includes comprehensive panels (Premium, Standard, Essential Checkup), specialty profiles (Heart Health, Fitness, Weight Loss, GLP-1, Thyroid), and routine chemistry and hematology panels (CMP, CBC, Lipid Panel, Iron Panel, Hepatic Function, Renal Function). Individual tests span cardiac markers (cholesterol, triglycerides, Lp(a), hsCRP), metabolic assessment (glucose, HbA1c), kidney function (creatinine, eGFR, BUN), liver enzymes (ALT, AST, ALP, bilirubin), electrolytes, proteins, hormones (TSH, Free T4, cortisol, vitamin D), CBC components (RBC, WBC differentials, platelets), and specialized markers (PSA, pregnancy hCG). Tests range from $15–$49. The company has published capillary equivalence studies in the Journal of Applied Laboratory Medicine (JALM) and serves consumers, clinicians, healthcare organizations, employers, payers, and retail pharmacy partners. BetterWay is available in Austin, Texas locations and expanding access through partner networks. The service emphasizes accessibility and affordability in blood testing.

Louisville APL Diagnostics manufactures in vitro diagnostic kits for the detection of antiphospholipid (aPL) antibodies, used in the diagnosis of Antiphospholipid Syndrome (APS). The company's FDA-cleared product portfolio includes the APhL ELISA Kit and APL ELISA Kit for detection of IgG, IgM, and IgA aPL antibodies; the LAPL aβ₂GPI HRP ELISA Kit for detection of IgG, IgM, and IgA anti-beta-2 Glycoprotein I antibodies; and calibrators and positive controls for anticardiolipin and β₂Glycoprotein 1 (for research use). Products are ELISA-based immunoassay reagents designed for clinical laboratory use in the diagnosis of APS, a thrombophilic disorder. The company maintains quality assurance protocols and regulatory compliance with FDA oversight. Louisville APL Diagnostics serves clinical laboratories, hematology and thrombosis centers, and research institutions requiring specialized diagnostic testing for antiphospholipid-related disorders.

Bio-Rad Laboratories is a global life science and clinical diagnostics company that manufactures and distributes instruments, reagents, consumables, controls, and data management software for research and diagnostics laboratories. The company serves academic research, industrial bioprocessing, and clinical diagnostic markets with a diverse product portfolio spanning PCR and qPCR systems (including proprietary ddPCR digital droplet technology), Western blotting reagents and systems, blood typing and screening products, immunoassay controls, antibodies, cell counting equipment, gel documentation and imaging systems, and process separation solutions for biopharmaceutical purification. Bio-Rad's offerings extend to quality control solutions, specialized testing kits for oncology mutation detection and infectious disease screening, and classroom education products. The company maintains robust e-commerce capabilities including PunchOut procurement integration, quick ordering, order status tracking, and document library management for B2B customers. Product lines include the QX200/QX600 ddPCR platforms, CFX Real-Time PCR systems, TC20 automated cell counters, ChemiDoc imaging systems, and specialized molecular detection kits. Bio-Rad serves clinical laboratories, research institutions, biotech firms, and educational organizations globally with regulatory credentials supporting ISO and FDA compliance across its diagnostics and instrument portfolios.

Helena Laboratories is a leading American manufacturer of clinical laboratory instruments and reagents with over 60 years of experience. The company specializes in gel and capillary electrophoresis systems for protein, immunofixation, hemoglobin, and cholesterol testing. Their product portfolio includes the SPIFE Nexus and V8 Nexus CE systems for automated gel and capillary electrophoresis with integrated reporting capabilities, the Touch Series (SPIFE Touch, ESH Touch, QS Touch Plus) for integrated gel electrophoresis with advanced data management and LIS interfaces, and point-of-care hemostasis instruments including Plateletworks for functional platelet analysis and Actalyke ACT analyzers for hemostatic monitoring. Helena also manufactures fecal occult blood (FOBT) test kits, hemostasis reagents, immunology and protein diagnostic systems, and disposable laboratory plasticware. The company maintains corporate headquarters and manufacturing facilities in Beaumont, Texas, comprising over 250,000 square feet of research, manufacturing, inventory, engineering, and administrative space. Helena holds over 40 registered patents and has been awarded the U.S. Secretary of Commerce "E" Award for export excellence. The company serves major medical centers, reference laboratories, hospitals, and private practices worldwide through three international subsidiaries and over 65 international distributors, supported by 24-hour technical hotline service and approximately 75 field specialists throughout the United States.

Vidan Diagnostics is a B2B medical diagnostic supplier headquartered in San Antonio, Texas, specializing in laboratory diagnostic reagents and assays for critical clinical areas. The company distributes high-quality, FDA-cleared diagnostic products focused on diabetes management, sepsis biomarker detection, cardiovascular disease assessment, and anemia diagnosis. As the exclusive U.S. distributor for DiaSys Diagnostic Systems' Procalcitonin FS Assay, Vidan serves hospital laboratories and clinical diagnostic facilities with proven, easy-to-use technology platforms. The company's product portfolio emphasizes biomarker-based testing to improve patient outcomes and reduce hospital mortality, particularly in sepsis and chronic disease management.

Micro Distributing is a leading supplier of innovative drug and alcohol testing products and services for over 20 years. The company manufactures and distributes the STATTEST brand of testing solutions including urine cups (StatCup), oral fluid tests, hair tests, alcohol analyzers, and reagents. They serve multiple markets: workplace testing (DOT and non-DOT compliant), government and criminal justice systems, educational institutions, behavioral health and addiction treatment facilities, and healthcare providers. The company offers comprehensive solutions including laboratory testing services, collection site networks, compliance management software (STATWARE platform), and DNA paternity testing. Micro Distributing holds FDA clearance, CE marking, CLIA waiver certifications, GMP compliance, and ISO 13485 registration. They are SAMHSA-certified and members of professional associations including DATIA, NDASA, and SAPAA, ensuring adherence to regulatory standards for workplace drug testing and diagnostics.

Carter BloodCare is a nonprofit community blood center based in Bedford, Texas, and one of the largest blood centers in the United States. Founded in 1951 through a series of mergers, the organization provides over 440,000 blood products annually to more than 200 hospitals and medical facilities across over 50 counties in North, Central, and East Texas. Carter BloodCare offers comprehensive blood services including collection, processing, specialized laboratory testing, storage, and distribution of blood and blood components. The organization conducts over 7,000 mobile blood drives annually, emphasizing community involvement and volunteer donor engagement. With a mission to save lives through transfusion, Carter BloodCare serves diverse patient needs and ensures steady supply of essential blood products to hospitals and healthcare facilities. The center operates with core values of accountability, excellence, and integrity.